capilliposide C

from Lysimachia capillipes; structure in first source

Networked: 3 relevant articles (1 outcomes, 0 trials/studies)

1.	Carcinoma (Carcinomatosis) 05/02/2017 - "Capilliposide C (CPS-C) is isolated from the Chinese herb Lysimachia capillipes Hemsl and is approved to be effective against carcinomas. "
2.	Prostatic Neoplasms (Prostate Cancer) 07/01/2014 - "Capilliposide C derived from Lysimachia capillipes Hemsl inhibits growth of human prostate cancer PC3 cells by targeting caspase and MAPK pathways."
3.	Neoplasms (Cancer) 01/01/2021 - "Lysimachia capillipes capilliposide C (LC-C), an extract from LC Hemsl, has demonstrated multiple anti-cancer effects in several types of cancer. "
4.	Lung Neoplasms (Lung Cancer) 01/01/2021 - "Capilliposide C from Lysimachia capillipes Restores Radiosensitivity in Ionizing Radiation-Resistant Lung Cancer Cells Through Regulation of ERRFI1/EGFR/STAT3 Signaling Pathway."
5.	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/02/2017 - "Capilliposide C Sensitizes Esophageal Squamous Carcinoma Cells to Oxaliplatin by Inducing Apoptosis Through the PI3K/Akt/mTOR Pathway."